• Custom Health restated its second-quarter 2026 financial statements following a British Columbia Securities Commission review.
• Corrections reduced the three-month net loss by approximately US$ 3 million to US$ 30.4 million.
• The six-month net loss decreased by approximately US$ 3 million to US$ 38.9 million.
• Total shareholders' deficit at June 30 fell by approximately US$ 3.2 million to US$ 24.9 million.
• A preliminary base shelf prospectus would permit securities offerings totaling up to $200 million over 25 months once final and effective.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Custom Health Holdings Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202611031700NEWSFILECNPR____20261103_322416_1) on November 03, 2026, and is solely responsible for the information contained therein.